Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; generally known as FRAP-related protein (FRP1)) has emerged for a promising technique for most cancers treatment method that exploits artificial lethal interactions with proteins associated with DNA destruction repair, overcomes resistance